Kilroy Realty Corp
Закрыт
СекторНедвижимость
36.91 -0.51
Обзор
Изменение цены акций
24 ч
Мин.
36.5
Макс.
37.55
Доход | -295M -19M |
|---|---|
Продажи | -2.2M 270M |
P/E Средняя по отрасли | 20.219 50.069 |
Прибыль на акцию | 0.16 |
Дивидендная доходность | 5.87 |
Рентабельность продаж | -7.135 |
Сотрудники | 241 |
EBITDA | -65M 118M |
Рекомендации | Нейтрально |
|---|---|
Прогноз на 12 месяцев | +2.38% upside |
Дивидендная доходность Средняя по отрасли | 5.87% 6.28% |
|---|---|
Следующий отчет о доходах | 27 июл. 2026 г. |
Дата следующей выплаты дивидендов | 8 июл. 2026 г. |
Следующая эксдивидендная дата | 30 июн. 2026 г. |
Рыночная капитализация | 530M 4.3B |
|---|---|
Предыдущая цена открытия | 37.42 |
Предыдущая цена закрытия | 36.91 |
Новостные настроения
By Acuity
100%
0%
154 / 167 Рейтинг в Real estate
Kilroy Realty Corp График
Прошлые результаты не являются надежным индикатором будущих результатов.
О компании Kilroy Realty Corp
Kilroy Realty Corporation (NYSE: KRC, the "Company", "Kilroy") is a leading U.S. landlord and developer, with operations in San Diego, Los Angeles, the San Francisco Bay Area, Seattle, and Austin. The Company has earned global recognition for sustainability, building operations, innovation, and design. As a pioneer and innovator in the creation of a more sustainable real estate industry, the Company's approach to modern business environments helps drive creativity and productivity for some of the world's leading technology, entertainment, life science, and business services companies. The Company is a publicly traded real estate investment trust ("REIT") and member of the S&P MidCap 400 Index with more than seven decades of experience developing, acquiring, and managing office, life science, and mixed-use projects. As of June 30, 2024, Kilroy's stabilized portfolio totaled approximately 17.0 million square feet of primarily office and life science space that was 83.7% occupied and 85.4% leased. The Company also had approximately 1,000 residential units in Hollywood and San Diego, which had a quarterly average occupancy of 92.8%. In addition, the Company had two in-process life science redevelopment projects totaling approximately 100,000 square feet with total estimated redevelopment costs of $80.0 million, and one approximately 875,000 square foot in-process development project with a total estimated investment of $1.0 billion.